Welcome to our dedicated page for Cvs Health news (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on Cvs Health stock.
News about CVS Health Corporation (NYSE: CVS) covers developments across its roles in retail pharmacy, pharmacy benefit management, health insurance and health care delivery. Company press releases and related disclosures highlight how CVS Health communicates financial performance, strategic priorities, governance updates and community initiatives to investors, customers and the public.
Investors following CVS stock can find news on quarterly and full-year earnings announcements, financial guidance updates and Investor Day presentations. For example, CVS Health has issued press releases discussing results for specific quarters, updating full-year financial guidance and providing outlooks for future years, including projections for revenues, operating income, adjusted operating income, GAAP diluted earnings (loss) per share and adjusted EPS. These communications often appear in conjunction with Form 8-K filings that furnish the underlying press releases.
Corporate governance and leadership changes are another recurring news theme. CVS Health has announced Board decisions such as appointing its President and Chief Executive Officer, J. David Joyner, to the additional role of Chair of the Board, and it has used both press releases and Form 8-K filings to describe these actions and related Board structures.
Operational and community-focused news items describe how CVS Health engages with public health and local organizations. Examples include offering the measles-mumps-rubella (MMR) vaccine at select CVS Pharmacy and MinuteClinic locations in South Carolina during a measles outbreak, and the CVS Health Foundation’s grants to the American Diabetes Association to expand a maternal diabetes program in New York City. Other stories highlight investments in affordable housing projects and the company’s reported economic impact across U.S. states.
Visitors to this news page can review these types of announcements to understand how CVS Health presents its strategy, financial outlook, health services, community partnerships and responses to health challenges over time.
CVS (NYSE: CVS) reported Q1 2026 total revenue of $100.4 billion, up 6.2% year-over-year, GAAP diluted EPS of $2.30 and Adjusted EPS of $2.57. The company raised full-year 2026 guidance to GAAP EPS $6.24–$6.44, Adjusted EPS $7.30–$7.50, and cash flow from operations to at least $9.5 billion.
Segment highlights include Health Care Benefits margin improvement (MBR 84.6%), Health Services revenue growth to $48.2 billion, and Pharmacy prescriptions up to 451.2 million (30-day equivalent).
CVS (NYSE: CVS) will update its most common commercial template formularies effective July 1, 2026 to prefer FDA‑approved biosimilars, including interchangeable options, to expand access and lower costs. Key moves include transitioning Stelara (ustekinumab) to biosimilars Pyzchiva and Yesintek and broader specialty category coverage.
The changes aim to reduce member out‑of‑pocket costs (most members may pay $0) and deliver client savings while providing communications and clinical support for transitions.
Aetna (NYSE: CVS) announced progress simplifying prior authorization to speed access to care. Key metrics: 88% of prior authorization volume standardized, 95%+ of eligible requests approved within 24 hours, 83% processed in real time, and over 1 million provider calls eliminated.
The company also launched bundled, condition-specific prior authorization programs and integrated medical and pharmacy decisions into single reviews to streamline approvals for patients and providers.
Aetna (NYSE: CVS) released results from the inaugural Aetna Provider Survey (Q1 2026), polling 827 U.S. providers (±3% margin). Key findings: 60% expect health care to become less burdensome in five years, trust score >50%, 65% accept prior authorization roles, and >95% of eligible PAs approved within 24 hours.
Aetna set a target of >80% real-time electronic prior authorizations by year-end 2026 and automated over 1 million provider calls about prior authorization in 2025.
CVS Health (NYSE: CVS) will hold its first quarter 2026 earnings conference call on Wednesday, May 6, 2026 at 8:00 a.m. ET. An audio webcast will stream on the company's investor relations site and will be archived there for one year.
Omnicare (NYSE: CVS) entered an asset purchase agreement with GenieRx, which will act as the stalking horse bidder in Omnicare's court‑supervised sale process.
The bid establishes a sale floor; competing bids are due April 30, 2026, an auction is expected May 5, 2026, and a court hearing to approve the winning bid will follow. Omnicare says it will continue serving skilled nursing and assisted living customers during the process.
CVS (NYSE:CVS) opened its first pharmacy-only location in Chicago on March 30, 2026, part of a plan to open nearly 20 pharmacy-only sites this year and more than 40 new CVS Pharmacy locations including traditional and Target stores. Sites average ~3,000 sq ft and focus on prescriptions, immunizations and pharmacist counseling.
The format complements existing store types and targets communities needing increased access to in-person pharmacy care.
CVS Health (NYSE: CVS) declared a quarterly dividend of $0.665 per share. The board approved the payment, which is payable on May 4, 2026 to shareholders of record on April 23, 2026.
This announcement details the dividend amount, record date, and payment date for common stockholders.
CVS Health (NYSE:CVS) is investing $2.24 million to launch a Health Zone in Charlotte's Historic West End through the Westside Wellness Collab led by LISC Charlotte.
The three‑year effort funds mobile clinics, fresh food distribution, care coordination and partner capacity building to improve chronic‑condition support and food access.
CVS Health (NYSE:CVS) announced a $2.24 million investment in Health Impact Ohio to launch a Health Zone in Columbus on March 10, 2026. The funding expands Community Health Worker capacity, maternal and behavioral health services, training and data systems to reduce avoidable emergency care and improve care coordination.
The investment builds on CVS's broader Ohio footprint, including workforce centers, affordable housing investments (~$80 million) and reported FY2024 economic contributions.